TB CARE I

in
PrintPrintE-mail E-mail

Date of Operation: 2010 – 2015

Primary Implementing Partner: Royal Netherlands Tuberculosis Association (KNCV)

Other Implementing Partners: World Health Organization (WHO), Management Sciences for Health (MSH)

Regions of Operation: Nationwide

Goal:

Improve case detection and treatment success rates of TB in Ethiopia.

Project Objectives:

  • Assist the Government of Ethiopia (GoE) in scaling up of drug management of Multi-Drug Resistant TB (MDR-TB)
  • Strengthen laboratory networking
  • Assist the GoE in the coordination of the TB control program

Description:

TB CARE I assists the GoE in addressing the country’s TB-specific challenges, including extremely low case detection, the emergence of multi-drug resistant (MDR) TB, and TB/HIV co-infection. To address these challenges, TB CARE I provides support on a national level in four major technical areas:

  • MDR-TB control scale up
  • Directly Observed Treatment Short Course expansion and enhancement
  • TB/HIV collaboration
  • Health system strengthening

TB CARE I also works with groups from Ethiopia’s STOP TB Partnership forum and the Ethiopian Health and Nutrition Research Institute (EHNRI) by providing technical, logistical and financial support to encourage the use of new technologies to improve case detection. TB CARE I works on USAID TB project sites until the HEAL TB project takes over sites in the three largest regions of Ethiopia, assisting in a smooth transition between projects and then to the local government.

Results:

  • Procurement of second line drugs to treat MDR-TB underway
  • Complete renovation of ALERT hospital and St. Peter’s hospital; MDR-TB treatment unit at ALERT hospital handed over to Ministry of Health
  • Support national TB prevalence survey by covering costs for short-term consultancies